Earnings Preview: Origin Bancorp

Origin Bancorp (NYSE:OBK) is set to give its latest quarterly earnings report on Wednesday, 2024-01-24. Here’s what investors…

Origin Bancorp (NYSE:OBK) is set to give its latest quarterly earnings report on Wednesday, 2024-01-24. Here’s what investors need to know before the announcement.

Analysts estimate that Origin Bancorp will report an earnings per share (EPS) of $0.62.

Origin Bancorp bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.07, which was followed by a 6.31% increase in the share price the next day.

Here’s a look at Origin Bancorp’s past performance and the resulting price change:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.64 0.67 0.91 0.99
EPS Actual 0.71 0.69 0.78 0.99
Price Change % 6.31% -2.95% -4.33% 0.49%

eps graph

Stock Performance

Shares of Origin Bancorp were trading at $33.28 as of January 22. Over the last 52-week period, shares are down 13.94%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Origin Bancorp visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Avanos Medical, Inc. Reports Preliminary Q4 And FY23 Financial Results; Revises Preliminary 2024 Revenue Outlook; Sees Q4 Revenue $170M-$173M Vs $179.27M Est.; FY23 Revenue $670M-$673M Vs $679.27M Est. ; FY24 Revenue $685M-$705M Vs $714.43M Est.

Avanos Medical, Inc. (NYSE:AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for

AVNS